VEGFA Antikörper (AA 27-190) (Biotin)
Kurzübersicht für VEGFA Antikörper (AA 27-190) (Biotin) (ABIN7178286)
Target
Alle VEGFA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 27-190
-
Verwendungszweck
- VEGFA Antibody, Biotin conjugated
-
Aufreinigung
- Protein G purified
-
Reinheit
- >95 %
-
Immunogen
- Recombinant Pig Vascular endothelial growth factor A protein (27-190AA)
-
Isotyp
- IgG
-
-
anti-Vascular Endothelial Growth Factor A (VEGFA) (AA 28-147) antibody
VEGFA Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Vascular Endothelial Growth Factor A (VEGFA) (AA 27-190) antibodyVEGFA Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Vascular Endothelial Growth Factor A (VEGFA) (AA 27-214) antibodyVEGFA Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Maus Monoclonal C2 unconjugated
anti-Vascular Endothelial Growth Factor A (VEGFA) (AA 27-126) antibodyVEGFA Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Vascular Endothelial Growth Factor A (VEGFA) (AA 207-371) antibodyVEGFA Reaktivität: Human WB, ELISA, ICC Wirt: Maus Monoclonal 6G5B5 unconjugated
anti-Vascular Endothelial Growth Factor A (VEGFA) antibodyVEGFA Reaktivität: Maus WB, ELISA, Neut Wirt: Kaninchen Polyclonal unconjugated
anti-Vascular Endothelial Growth Factor A (VEGFA) (AA 33-48), (N-Term) antibodyVEGFA Reaktivität: Human, Ratte, Maus WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Vascular Endothelial Growth Factor A (VEGFA) (AA 27-191) antibodyVEGFA Reaktivität: Human, Ratte, Maus WB, IHC, FACS Wirt: Kaninchen Polyclonal unconjugated
anti-Vascular Endothelial Growth Factor A (VEGFA) (AA 207-371) antibodyVEGFA Reaktivität: Human WB, ELISA, FACS Wirt: Maus Monoclonal 6G5A10 unconjugated
anti-Vascular Endothelial Growth Factor A (VEGFA) (AA 27-130) antibodyVEGFA Reaktivität: Human WB, ELISA, PLA Wirt: Maus Monoclonal 3F7 unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- VEGFA (Vascular Endothelial Growth Factor A (VEGFA))
-
Andere Bezeichnung
- VEGFA
-
Hintergrund
-
Background: Growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. Induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels. Binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin
Aliases: VEGFA antibody, VEGFVascular endothelial growth factor A antibody, VEGF-A antibody, Vascular permeability factor antibody, VPF antibody
-
UniProt
- P49151
-
Pathways
- RTK Signalweg, Glycosaminoglycan Metabolic Process, Regulation of Cell Size, Tube Formation, Signaling Events mediated by VEGFR1 and VEGFR2, Platelet-derived growth Factor Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling
Target
-
